04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report

demonstrated elevated total red blood cell porphyrin of 36.1 umol/L RBC (reference range <1.8) with normal levels of zinc protoporphyrin 1.3 umol/L RBC (reference range <1.6).Liver function tests were unremarkable.She was mildly anaemic, in keeping with MDS.A diagnosis of erythropoietic protoporphyria was made.She was able to cease prednisolone and antihistamines.We counselled her on the need to avoid sun exposure and implement strict sun protection strategies.Presently, she continues venetoclax monotherapy.A bone marrow transplant would potentially be curative for both MDS and EPP however, she has previously been deemed inappropriate due to her age.While acquired EPP is a rare entity, our case exemplifies the need to screen for EPP in patients of any age where there is clinical suspicion, especially in patients with an underlying haematological disorder.Treatment of the abnormal bone marrow clone with chemotherapy temporarily reduces EPP symptoms.

Authors

Institutions

Publication Details

Published
2024-09-01
DOI
https://doi.org/10.1136/bmjgast-2024-icpp.84
Primary Topic
Porphyrin Metabolism and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report

Giada Di Betto, Elena Corradini, Marcello Bianchini, Antonello Pietrangelo et al.
Porphyrin Metabolism and Disorders
article

04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report

Giada Di Betto, Elena Corradini, Marcello Bianchini, Antonello Pietrangelo, Filippo Schepis, Stefano Marchini, Dario Saltini, Paolo Ventura, Andrea Ricci, Camilla Mancini
article en

Abstract

demonstrated elevated total red blood cell porphyrin of 36.1 umol/L RBC (reference range <1.8) with normal levels of zinc protoporphyrin 1.3 umol/L RBC (reference range <1.6).Liver function tests were unremarkable.She was mildly anaemic, in keeping with MDS.A diagnosis of erythropoietic protoporphyria was made.She was able to cease prednisolone and antihistamines.We counselled her on the need to avoid sun exposure and implement strict sun protection strategies.Presently, she continues venetoclax monotherapy.A bone marrow transplant would potentially be curative for both MDS and EPP however, she has previously been deemed inappropriate due to her age.While acquired EPP is a rare entity, our case exemplifies the need to screen for EPP in patients of any age where there is clinical suspicion, especially in patients with an underlying haematological disorder.Treatment of the abnormal bone marrow clone with chemotherapy temporarily reduces EPP symptoms.

University of Modena and Reggio Emilia (IT), Azienda Ospedaliero-Universitaria di Modena (IT)
Zero hunger
Openalex Percentile: Top 86%
Porphyrin Metabolism and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report — Giada Di Betto, Elena Corradini, et al. · (2024) | TGRS Research Map | TGRS